TG THERAPEUTICS, INC. Inventory, Finished Goods and Work in Process, Net of Reserves
TG THERAPEUTICS, INC. (TGTX) had Inventory, Finished Goods and Work in Process, Net of Reserves of $21.09 million as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsAndWorkInProcessNetOfReserves · last filed 2025-11-05
- 2025-09-30: Inventory, Finished Goods and Work in Process, Net of Reserves $21.09M.
- 2025-06-30: Inventory, Finished Goods and Work in Process, Net of Reserves $21.84M.
- 2025-03-31: Inventory, Finished Goods and Work in Process, Net of Reserves $10.72M.
- 2024-12-31: Inventory, Finished Goods and Work in Process, Net of Reserves $13.94M.
| Period end | Inventory, Finished Goods and Work in Process, Net of Reserves |
|---|---|
| 2025-09-30 | $21.09M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $21.84M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $10.72M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $13.94M 10-Q · filed 2025-11-05 |
| 2024-09-30 | $7.96M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.61M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.90M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $2.00M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |